409 related articles for article (PubMed ID: 21700876)
1. A synthetic optogenetic transcription device enhances blood-glucose homeostasis in mice.
Ye H; Daoud-El Baba M; Peng RW; Fussenegger M
Science; 2011 Jun; 332(6037):1565-8. PubMed ID: 21700876
[TBL] [Abstract][Full Text] [Related]
2. Physiology. Synthetic physiology.
Chow BY; Boyden ES
Science; 2011 Jun; 332(6037):1508-9. PubMed ID: 21700858
[No Abstract] [Full Text] [Related]
3. Optogenetic therapeutic cell implants.
Ausländer D; Fussenegger M
Gastroenterology; 2012 Aug; 143(2):301-6. PubMed ID: 22721803
[No Abstract] [Full Text] [Related]
4. Mammalian cell lines engineered to identify inhibitors of specific signal transduction pathways.
Jones RE; Defeo-Jones D; McAvoy EM; Vuocolo GA; Wegrzyn RJ; Haskell KM; Oliff A
Oncogene; 1991 May; 6(5):745-51. PubMed ID: 1711189
[TBL] [Abstract][Full Text] [Related]
5. Engineered glucagon-like peptide-1-producing hepatocytes lower plasma glucose levels in mice.
Riedel MJ; Lee CW; Kieffer TJ
Am J Physiol Endocrinol Metab; 2009 Apr; 296(4):E936-44. PubMed ID: 19190262
[TBL] [Abstract][Full Text] [Related]
6. A synthetic metabolite-based mammalian inter-cell signaling system.
Weber W; Schuetz M; Dénervaud N; Fussenegger M
Mol Biosyst; 2009 Jul; 5(7):757-63. PubMed ID: 19562115
[TBL] [Abstract][Full Text] [Related]
7. Gene therapy of diabetes using a novel GLP-1/IgG1-Fc fusion construct normalizes glucose levels in db/db mice.
Kumar M; Hunag Y; Glinka Y; Prud'homme GJ; Wang Q
Gene Ther; 2007 Jan; 14(2):162-72. PubMed ID: 16943856
[TBL] [Abstract][Full Text] [Related]
8. Vitamin H-regulated transgene expression in mammalian cells.
Weber W; Bacchus W; Daoud-El Baba M; Fussenegger M
Nucleic Acids Res; 2007; 35(17):e116. PubMed ID: 17827215
[TBL] [Abstract][Full Text] [Related]
9. Gas-inducible transgene expression in mammalian cells and mice.
Weber W; Rimann M; Spielmann M; Keller B; Daoud-El Baba M; Aubel D; Weber CC; Fussenegger M
Nat Biotechnol; 2004 Nov; 22(11):1440-4. PubMed ID: 15502819
[TBL] [Abstract][Full Text] [Related]
10. A novel mammalian expression system derived from components coordinating nicotine degradation in arthrobacter nicotinovorans pAO1.
Malphettes L; Weber CC; El-Baba MD; Schoenmakers RG; Aubel D; Weber W; Fussenegger M
Nucleic Acids Res; 2005 Jul; 33(12):e107. PubMed ID: 16002786
[TBL] [Abstract][Full Text] [Related]
11. Macrolide-based transgene control in mammalian cells and mice.
Weber W; Fux C; Daoud-el Baba M; Keller B; Weber CC; Kramer BP; Heinzen C; Aubel D; Bailey JE; Fussenegger M
Nat Biotechnol; 2002 Sep; 20(9):901-7. PubMed ID: 12205509
[TBL] [Abstract][Full Text] [Related]
12. Adenoviral vector-mediated glucagon-like peptide 1 gene therapy improves glucose homeostasis in Zucker diabetic fatty rats.
Lee Y; Kwon MK; Kang ES; Park YM; Choi SH; Ahn CW; Kim KS; Park CW; Cha BS; Kim SW; Sung JK; Lee EJ; Lee HC
J Gene Med; 2008 Mar; 10(3):260-8. PubMed ID: 18085721
[TBL] [Abstract][Full Text] [Related]
13. Inducible gene expression in mammalian cells and mice.
Weber W; Fussenegger M
Methods Mol Biol; 2004; 267():451-66. PubMed ID: 15269442
[TBL] [Abstract][Full Text] [Related]
14. Differentiation-inducing factor-1 alters canonical Wnt signaling and suppresses alkaline phosphatase expression in osteoblast-like cell lines.
Matsuzaki E; Takahashi-Yanaga F; Miwa Y; Hirata M; Watanabe Y; Sato N; Morimoto S; Hirofuji T; Maeda K; Sasaguri T
J Bone Miner Res; 2006 Aug; 21(8):1307-16. PubMed ID: 16869729
[TBL] [Abstract][Full Text] [Related]
15. A gas-inducible expression system in HEK.EBNA cells applied to controlled proliferation studies by expression of p27(Kip1).
Werner NS; Weber W; Fussenegger M; Geisse S
Biotechnol Bioeng; 2007 Apr; 96(6):1155-66. PubMed ID: 17058277
[TBL] [Abstract][Full Text] [Related]
16. Synthetic gene networks in mammalian cells.
Weber W; Fussenegger M
Curr Opin Biotechnol; 2010 Oct; 21(5):690-6. PubMed ID: 20691580
[TBL] [Abstract][Full Text] [Related]
17. Addition of human melanopsin renders mammalian cells photoresponsive.
Melyan Z; Tarttelin EE; Bellingham J; Lucas RJ; Hankins MW
Nature; 2005 Feb; 433(7027):741-5. PubMed ID: 15674244
[TBL] [Abstract][Full Text] [Related]
18. Rewiring and dosing of systems modules as a design approach for synthetic mammalian signaling networks.
Kämpf MM; Engesser R; Busacker M; Hörner M; Karlsson M; Zurbriggen MD; Fussenegger M; Timmer J; Weber W
Mol Biosyst; 2012 Jun; 8(6):1824-32. PubMed ID: 22532387
[TBL] [Abstract][Full Text] [Related]
19. Identification of the tyrosine phosphatase PTP-MEG2 as an antagonist of hepatic insulin signaling.
Cho CY; Koo SH; Wang Y; Callaway S; Hedrick S; Mak PA; Orth AP; Peters EC; Saez E; Montminy M; Schultz PG; Chanda SK
Cell Metab; 2006 May; 3(5):367-78. PubMed ID: 16679294
[TBL] [Abstract][Full Text] [Related]
20. Toward higher order control modalities in mammalian cells-independent adjustment of two different gene activities.
Fux C; Fussenegger M
Biotechnol Prog; 2003; 19(1):109-20. PubMed ID: 12573013
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
